Opportunity Information: Apply for RFA EY 22 001

The NIH funding opportunity titled "A Community Research Resource: Characterization of the Resident Ocular Microbiome (U24 Clinical Trial Not Allowed)" (RFA-EY-22-001) supports the creation of a shared, community-focused research resource that maps and explains the microbial communities that normally live on the front of the eye in healthy people. The central goal is not to run a clinical trial, but to build a foundational dataset and related tools that other researchers can use to better understand what a "healthy" ocular microbiome looks like, how stable or variable it is across individuals, and what biological signals it produces that might influence human physiology. Because it is structured as a U24 cooperative agreement, the project is expected to operate as a coordinated, collaborative resource effort with substantial involvement from the funding institute, rather than as an isolated investigator-driven study.

Scientifically, the FOA is aimed at defining the core microbial constituents of the anterior segment and clarifying their functional relationships with the host. The anterior segment is described broadly to include the ocular surface and nearby structures such as the cornea, conjunctiva, eyelids, periocular skin, iris, ciliary body, and lens. A major emphasis is on characterizing the microbiome of the ocular surface and related front-of-eye niches in healthy individuals, then linking those microbial profiles to immune and neural interactions that help maintain homeostasis. In other words, the opportunity is pushing beyond a simple list of organisms and toward understanding how these microbial communities interact with local immune defenses, sensory and autonomic pathways, and other host processes that keep the ocular surface stable and resilient.

A key deliverable envisioned by the announcement is an integrated resource that combines microbiome measurements with broader "omics" and clinical information to identify patterns associated with ocular surface health. This integration implies that funded teams should be able to connect microbial community composition and potential function to host-relevant data streams, with the end goal of determining profiles that promote or reflect healthy ocular surface conditions. The FOA also signals interest in identifying factors produced or "elaborated" by microbial communities that can affect human physiology, which points toward functional readouts such as microbial metabolites, proteins, or other molecular products, and how these might shape local biology at the eye.

Administratively, this is a discretionary grant opportunity from the National Institutes of Health, categorized under health research and funded through a cooperative agreement mechanism. The CFDA number listed is 93.867. The original closing date provided in the source material was 2022-07-06, and the opportunity was created on 2022-04-06. The award ceiling and expected number of awards are not specified in the provided listing, so applicants would normally need to consult the full FOA text for budget expectations, project period, and any caps or cost-sharing details.

Eligibility is broad and includes many types of organizations that could contribute to a multidisciplinary, community resource effort. Eligible applicants include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly highlights additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, faith-based or community-based organizations, eligible federal agencies, regional organizations, non-U.S. entities (foreign organizations), and U.S. territories or possessions. This breadth is consistent with the stated goal of creating a community-facing resource where different kinds of institutions can contribute expertise in microbiology, immunology, neuroscience, ophthalmology, bioinformatics, and data integration.

Overall, the opportunity is best understood as infrastructure-building for the eye research community: it funds teams to generate and organize high-quality, standardized microbial and related molecular/clinical data from healthy anterior segment sites, interpret how these microbes may interact with immune and neural systems to support normal ocular surface function, and deliver an integrated resource that helps establish what "healthy" looks like at the microbial level. The long-term value is that a well-characterized baseline resource can make it easier for future studies to recognize meaningful deviations linked to disease, treatment effects, environmental influences, or risk factors, even though this specific FOA is focused on healthy individuals and explicitly does not allow clinical trials.

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "A Community Research Resource: Characterization of the Resident Ocular Microbiome. (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.867.
  • This funding opportunity was created on 2022-04-06.
  • Applicants must submit their applications by 2022-07-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for RFA EY 22 001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Frequently Asked Questions (FAQs)

What is the title and FOA number of this NIH grant opportunity?

The funding opportunity is titled "A Community Research Resource: Characterization of the Resident Ocular Microbiome (U24 Clinical Trial Not Allowed)" and the FOA number is RFA-EY-22-001.

What is the main purpose of this funding opportunity?

The purpose is to create a shared, community-focused research resource that characterizes the resident microbial communities on the front of the eye in healthy people. The emphasis is on building a foundational dataset and related tools that other researchers can use to understand what a "healthy" ocular microbiome looks like and how it may influence ocular physiology.

Is this opportunity intended to fund a clinical trial?

No. The FOA is explicitly marked "Clinical Trial Not Allowed." The central goal is to build a research resource rather than to conduct a clinical trial.

What does it mean that this is a U24 cooperative agreement?

A U24 cooperative agreement is a funding mechanism used for coordinated, collaborative resource efforts. It implies substantial involvement from the funding institute and an expectation that the project will function as a community resource rather than as a standalone investigator-driven study.

What is meant by a "community research resource" in this context?

It refers to an organized, shared infrastructure or dataset intended to benefit the broader research community. Here, it means generating standardized information about the healthy ocular microbiome and delivering data and related tools that other researchers can use as a baseline for future investigations.

What part of the eye is the focus of the microbiome characterization?

The focus is the anterior segment, described broadly to include the ocular surface and nearby structures such as the cornea, conjunctiva, eyelids, periocular skin, iris, ciliary body, and lens. A major emphasis is on the ocular surface and related front-of-eye niches.

What population is primarily being studied under this FOA?

The FOA emphasizes characterizing the ocular microbiome in healthy individuals to establish baseline patterns of microbial community composition, stability, and functional signals associated with ocular surface health.

What scientific questions is the FOA trying to address?

The FOA aims to define the core microbial constituents of the anterior segment and clarify their functional relationships with the host. This includes understanding how stable or variable these microbial communities are across individuals and identifying biological signals they produce that might influence human physiology.

Does the FOA focus only on identifying which microbes are present?

No. The FOA pushes beyond cataloging organisms and emphasizes understanding functional relationships, including links between microbial profiles and host immune and neural interactions that maintain ocular surface homeostasis.

What types of host interactions are highlighted in the FOA?

The FOA highlights immune and neural interactions, including local immune defenses and sensory and autonomic pathways, as important components for understanding how microbial communities may support or influence ocular surface stability and resilience.

What deliverables are envisioned by the announcement?

A key envisioned deliverable is an integrated resource that combines microbiome measurements with broader "omics" and clinical information to identify patterns associated with ocular surface health. The output is intended to be usable by other researchers as a reference and foundation.

What does "integrated resource" mean here?

It means bringing together multiple data streams, including microbiome data and additional "omics" and clinical information, to allow identification of profiles that promote or reflect healthy ocular surface conditions.

What kinds of "omics" or functional readouts are suggested by the FOA?

The FOA signals interest in factors produced or elaborated by microbial communities that can affect human physiology. This points toward functional readouts such as microbial metabolites, proteins, or other molecular products, and how they may shape local biology at the eye.

Why is building a baseline resource for healthy individuals important?

The stated long-term value is that a well-characterized baseline can help future studies recognize meaningful deviations linked to disease, treatment effects, environmental influences, or risk factors. This FOA itself is focused on healthy individuals to establish what "healthy" looks like at the microbial level.

Which NIH institute is associated with this FOA based on the identifier?

The FOA identifier includes "EY," and the topic is eye-focused, indicating the opportunity is associated with NIH eye research. (The provided information describes it as an NIH funding opportunity and does not name an institute explicitly beyond the context of eye research.)

What is the CFDA number listed for this opportunity?

The CFDA number listed is 93.867.

When was this opportunity created and what was the listed closing date?

The opportunity was created on 2022-04-06, and the original closing date listed in the provided information was 2022-07-06.

Is the award ceiling or expected number of awards provided in the listing?

No. The award ceiling and the expected number of awards are not specified in the provided listing. Applicants would typically consult the full FOA text for budget expectations, project period, and any caps or cost-sharing details.

What type of funding opportunity is this administratively?

It is described as a discretionary grant opportunity from the National Institutes of Health, categorized under health research, and funded through a cooperative agreement mechanism (U24).

What kinds of organizations are eligible to apply?

Eligibility is broad and includes state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized tribal governments; tribal organizations that are not federally recognized; public housing authorities and Indian housing authorities; nonprofits with and without 501(c)(3) status; for-profit organizations (other than small businesses); and small businesses.

Are minority-serving institutions and community-based organizations eligible?

Yes. The FOA explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, AANAPISISs, Hispanic-serving institutions, Historically Black Colleges and Universities, Tribally Controlled Colleges and Universities, and faith-based or community-based organizations.

Are federal agencies or regional organizations eligible to apply?

Yes. The FOA explicitly lists eligible federal agencies and regional organizations among eligible applicant categories.

Are non-U.S. entities eligible to apply?

Yes. The FOA explicitly includes non-U.S. entities (foreign organizations) as eligible applicants, and also includes U.S. territories or possessions.

What kinds of expertise might be relevant for a competitive application?

Based on the described scope, relevant expertise could include microbiology, immunology, neuroscience, ophthalmology, bioinformatics, and data integration, consistent with building a multidisciplinary community resource.

How is this opportunity best understood in terms of its overall goal?

It is best understood as infrastructure-building for the eye research community: generating and organizing high-quality, standardized microbial and related molecular/clinical data from healthy anterior segment sites, interpreting host-microbe interactions relevant to ocular surface homeostasis, and delivering an integrated resource that others can use.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: BRAIN Initiative: Team-Research BRAIN Circuit Programs - TeamBCP (U19 Basic Experimental Studies with Humans Required)

Previous opportunity: New Beginning for Tribal Students Program

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA EY 22 001

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFA EY 22 001) also looked into and applied for these:

Funding Opportunity
Limited Competition: Research Centers in Minority Institutions (RCMI) Clinical Research Network for Health Equity (UG3/UH3 - Clinical Trial Optional) Apply for RFA MD 22 006

Funding Number: RFA MD 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional) Apply for RFA RM 22 019

Funding Number: RFA RM 22 019
Agency: National Institutes of Health
Category: Health
Funding Amount: $900,000
Alcohol Treatment and Recovery Research (R01 Clinical Trial Required) Apply for PAR 22 158

Funding Number: PAR 22 158
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Health Services Research (R34 Clinical Trial Optional) Apply for PAR 22 157

Funding Number: PAR 22 157
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
Alcohol Health Services Research (R01 Clinical Trial Optional) Apply for PAR 22 156

Funding Number: PAR 22 156
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Alcohol Treatment and Recovery Research (R34 Clinical Trial Required) Apply for PAR 22 159

Funding Number: PAR 22 159
Agency: National Institutes of Health
Category: Health
Funding Amount: $450,000
AHRQ Administrative Supplements for Grants in Health Services Research Apply for PA 22 168

Funding Number: PA 22 168
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: Case Dependent
Diagnostic Centers of Excellence: Partnerships to Improve Diagnostic Safety and Quality (R18) Apply for RFA HS 22 008

Funding Number: RFA HS 22 008
Agency: Agency for Health Care Research and Quality
Category: Health
Funding Amount: $4,000,000
Somatic Cell Genome Editing Program Translational Coordination and Dissemination Center (TCDC) (U24 - Clinical Trial Not Allowed) Apply for RFA RM 22 017

Funding Number: RFA RM 22 017
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
IND-enabling Studies of Somatic Genome Editing Therapeutic Leads (U19, Clinical Trial Not allowed) Apply for RFA RM 22 015

Funding Number: RFA RM 22 015
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) Apply for RFA RM 22 014

Funding Number: RFA RM 22 014
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required) Apply for RFA RM 22 016

Funding Number: RFA RM 22 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Cooperative Agreement for Early-Stage Clinical Trials with Greater than Minimal Risk (U01 Clinical Trial Required) Apply for PAR 22 149

Funding Number: PAR 22 149
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
IDeA Clinical Research Resource Center (U24 Clinical Trial Not Allowed) Apply for PAR 22 150

Funding Number: PAR 22 150
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,800,000
NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional) Apply for RFA RM 22 018

Funding Number: RFA RM 22 018
Agency: National Institutes of Health
Category: Health
Funding Amount: $700,000
Transition to Aging Research for Predoctoral Students (F99/K00 Clinical Trial Not Allowed) Apply for RFA AG 23 016

Funding Number: RFA AG 23 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Comprehensive Alcohol Research Centers (P60 Clinical trial Optional) Apply for RFA AA 22 002

Funding Number: RFA AA 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,250,000
Specialized Alcohol Research Centers (P50 Clinical trial Optional) Apply for RFA AA 22 001

Funding Number: RFA AA 22 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,150,000
Pilot Projects Investigating Understudied G Protein-Coupled Receptors, Ion Channels, and Protein Kinases (R03 Clinical Trial Not Allowed) Apply for RFA RM 22 024

Funding Number: RFA RM 22 024
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required) Apply for PAR 22 142

Funding Number: PAR 22 142
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA EY 22 001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: